These final results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assist the idea of focusing on ACKR3 as a unique way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-associated Problems. Publishing this review https://johny691yto0.blogdemls.com/profile